Acelyrin Newsroom

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Cabaletta Bio (CABA) and Mersana Therapeutics (MRSN)

TipRanksNov 15 18:32

Vikram Purohit's Hold Rating on ACELYRIN, INC.: Awaiting Key Data and Trial Progress for Future Stock Movement

TipRanksNov 15 18:32

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Futu NewsNov 15 18:31

ACELYRIN Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 15 02:42

Acelyrin Analyst Ratings

BenzingaNov 15 02:33

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 14 21:34

TD Cowen Maintains Acelyrin(SLRN.US) With Buy Rating

Futu NewsNov 14 21:34

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $8 to $20

Futu NewsNov 14 21:06

Acelyrin's Phase 3 Trial Progress and Uncertainties Lead to Hold Rating

TipRanksNov 14 19:20

ACELYRIN Is Maintained at Overweight by Wells Fargo

Dow JonesOct 16 23:52

Acelyrin Analyst Ratings

BenzingaOct 16 23:44

Wells Fargo Maintains Acelyrin(SLRN.US) With Buy Rating, Raises Target Price to $15

Futu NewsOct 16 18:31

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Futu NewsSep 25 19:31

ACELYRIN, INC. (SLRN) Receives a Buy From Piper Sandler

TipRanksSep 25 19:29

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Futu NewsAug 20 20:33

Acelyrin Analyst Ratings

BenzingaAug 20 01:00

Morgan Stanley Maintains Equal-Weight on Acelyrin, Lowers Price Target to $6

BenzingaAug 20 01:00

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Cuts Target Price to $6

Futu NewsAug 19 21:31

ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway

TipRanksAug 19 20:47

HC Wainwright & Co. Downgrades Acelyrin to Neutral, Lowers Price Target to $6

BenzingaAug 16 01:22